Visualitzant O - Articles científics per títol

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers

Ros, Javier; Baraibar, Iosune; Saoudi Gonzalez, Nadia; R Castells, Marta; Salvà, Francesc; Tabernero, Josep; Elez, Elena (MDPI, 2023-08-24)

Immunotherapy for early triple negative breast cancer: research agenda for the next decade

Tarantino, Paolo; Corti, Chiara; Cortés Castan, Javier; Mittendorf, Elizabeth; Schmid, Peter; Rugo, Hope (Nature Research, 2022-02-18)

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer

Elez Fernandez, Mª Elena; Chianese, Chiara; Matito Ariza, Judit; Macarulla Mercadé, Teresa; Argilés Martinez, Guillem; Garcia Rodriguez, Ariadna; Mulet Margalef, Núria; Tabernero Caturla, Josep; Vivancos Prellezo, Ana; Sanz Garcia, Enrique; Martinelli, Erica; Noguerido Castro, Alba; Mancuso, Francesco Mattia; Caratù, Ginevra; Grasselli, Julieta; Martini, Giulia; Capdevila Castillon, Jaume (FEBS Press, 2019-07-31)

Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis

García Fortes, María; Alvarez-Larran, Alberto; Raya, José M.; Angona, Anna; Estrada, Natalia; Fox, Maria Laura; Hernandez-Boluda, Juan Carlos (MDPI, 2022-05)

Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial

Fakih, Marwan; Prager, M.D., Gerald; Van Cutsem, Eric; Tabernero, Josep; taieb, julien; Ciardiello, Fortunato (Elsevier, 2024-03)

Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis

Papakonstantinou, Andri; Fredriksson, Irma; Matikas, Alexios; Villacampa Javierre, Guillermo (Oxford University Press, 2024-01)

Impact of the COVID-19 pandemic in the early-onset colorectal cancer

Baraibar Argota, Iosune; Garcia Rodriguez, Ariadna; Salva Ballabrera, Francesc; Ros Montañá, Fco. Javier; Castillo Cicuendez, Gloria; Sanchis Marin, Mireia; Garcia Alvarez, Alejandro; Hernando Cubero, Jorge; Rodríguez Castells, Marta; Martí Gallostra, Marc; Espín Basany, Eloy; Navalpotro Yagüe, Begoña; Guevara Cubas, Jorge Alonso; Dopazo Taboada, Cristina; Nuciforo, Paolo Giovanni; Vivancos Prellezo, Ana; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena; Capdevila Castillon, Jaume; Landolfi, Stefania; Saoudi Gonzalez, Nadia; Comas Navarro, Raquel (Elsevier, 2023-06)

Impact of the number of prior chemotherapy regimens on outcomes for patients with metastatic breast cancer treated with eribulin: a post hoc pooled analysis

Cortés Castan, Javier; Twelves, Chris (Wiley, 2020-07)

Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction

Inserte Igual, Javier; Barrabés Riu, José Antonio; Aluja Gonzalez, David; Otaegui Irurueta, Imanol; Bañeras Rius, Jordi; Castellote Bellés, Laura; Sánchez Sánchez, Ana; Mila Pascual, Laia; Lidón Corbi, Rosa María; De Carvalho Negrao Valente, Filipa Xavier; Rafecas Ventosa, Agnès; Rodríguez Sinovas, Antonio; Benito Villabriga, Begoña; Buera Surribas, Irene; Delgado Tomás, Sara; Ferreira González, Ignacio; Beneitez Pastor, David; Ruiz Meana, Marisol; Miro Casas, Elisabet; Rodríguez Palomares, Jose Fernando; Sambola Ayala, Antonia (Elsevier, 2021-07)

Improving access to oncology publications for advocates and people with cancer

Tabernero Caturla, Josep; Bowling, Tami Eagle; Rivers, Jamil; Chari, Dheepa; Ghith, Jennifer; Ferdinand, Roxanne; Shanahan, Kelly; Shore, Neal (Wiley, 2022-11-01)

IMscin001 Part 2: a randomised phase III, open-label, multicentre study examining the pharmacokinetics, efficacy, immunogenicity, and safety of atezolizumab subcutaneous versus intravenous administration in previously treated locally advanced or metastatic non-small-cell lung cancer and pharmacokinetics comparison with other approved indications

Burotto, Mauricio; Zvirbule, Z.; Mochalova, A.; Runglodvatana, Y.; Herraez-Baranda, L.; Liu, S.N.; FELIP, ENRIQUETA (Elsevier, 2023-08)

Inactivation of EMILIN-1 by Proteolysis and Secretion in Small Extracellular Vesicles Favors Melanoma Progression and Metastasis

Amor López, Ana; Mazariegos, Marina S.; Capuano, Alessandra; Ximénez-Embún, Pilar; Hergueta-Redondo, Marta; Recio Conde, Juan Angel; Muñoz Couselo, Eva (MDPI, 2021-07-09)

Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice

Sabaté Gallego, Mònica; Pérez Esquirol, Eulalia; García Doladé, Núria; Vidal Guitart, Xavier; Farriols Danes, Anna Maria; Felip Font, Enriqueta; Braña Garcia, Irene; Carles Galceran, Joan; Morales Barrera, Rafael; Agustí Escasany, Maria Antònia; Carreras Soler, Maria Josep; Muñoz Couselo, Eva (Frontiers Media, 2022-08-22)

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design

Miguel-Huguet, Bernat; Perez-Garcia, Jose Manuel; Páez, David; Guerrero‑Zotano, Angel; Garde-Noguera, Javier; Cortés Castan, Javier; Sampayo-Cordero, Miguel (Elsevier, 2020-11-01)

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model

Mavaddat, Nasim; Ficorella, Lorenzo; Carver, Tim; Lee, Andrew; Cunningham, Alex P.; Lush, Michael; Pardo Muñoz, Monica; Balmaña Gelpí, Judith (American Association for Cancer Research, 2023-03-01)

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis

Bartoletti, Michele; Montico, Marcella; Lorusso, Domenica; Mazzeo, Roberta; OAKNIN, ANA; Musacchio, lucia (Elsevier, 2024-02-27)

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Krajewska, Jolanta; Hernando, Jorge; Robinson, Bruce; Capdevila Castillon, Jaume; Sherman, Steven; Jarząb, Barbara (Mary Ann Liebert, 2024-03)

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Perez, Ariel; Jurinovic, Vindi; Holtick, Udo; Rejeski, Kai; IACOBONI, GLORIA; Bücklein, Veit (Wolters Kluwer Health, 2023-07-11)

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia

Ramiro Pascual, Laura; Faura Llorens, Julia; Simats Oriol, Alba; Garcia Rodriguez, Paula; Ma, Feifei; Martín Castel, Luna; Canals Suris, Francesc; Montaner Villalonga, Joan; Rosell Novel, Anna (BMC, 2023-01-27)

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors

Li, Qing; Jiang, Baishan; Guo, Jiaye; Shao, Hong; Del Priore, Isabella; Chang, Qing; Palafox Sánchez, Marta; Serra Elizalde, Violeta (American Association for Cancer Research, 2022-02-01)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Visualitzant VHIO - Articles científics per títol

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers

Immunotherapy for early triple negative breast cancer: research agenda for the next decade

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer

Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis

Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial

Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis

Impact of the COVID-19 pandemic in the early-onset colorectal cancer

Impact of the number of prior chemotherapy regimens on outcomes for patients with metastatic breast cancer treated with eribulin: a post hoc pooled analysis

Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction

Improving access to oncology publications for advocates and people with cancer

Inactivation of EMILIN-1 by Proteolysis and Secretion in Small Extracellular Vesicles Favors Melanoma Progression and Metastasis

Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Visualitzant VHIO - Articles científics per títol

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers ﻿

Immunotherapy for early triple negative breast cancer: research agenda for the next decade ﻿

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer ﻿

Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis ﻿

Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial ﻿

Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis ﻿

Impact of the COVID-19 pandemic in the early-onset colorectal cancer ﻿

Impact of the number of prior chemotherapy regimens on outcomes for patients with metastatic breast cancer treated with eribulin: a post hoc pooled analysis ﻿

Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction ﻿

Improving access to oncology publications for advocates and people with cancer ﻿

Inactivation of EMILIN-1 by Proteolysis and Secretion in Small Extracellular Vesicles Favors Melanoma Progression and Metastasis ﻿

Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice ﻿

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design ﻿

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model ﻿

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis ﻿

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study ﻿

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use ﻿

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia ﻿

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors ﻿

Coneix Scientia

Guies i ajudes

Directe a...

Coneix Scientia

Guies i ajudes

Directe a...

Immunotherapy for Colorectal Cancer with High Microsatellite Instability: The Ongoing Search for Biomarkers

Immunotherapy for early triple negative breast cancer: research agenda for the next decade

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer

Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis

Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial

Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis

Impact of the COVID-19 pandemic in the early-onset colorectal cancer

Impact of the number of prior chemotherapy regimens on outcomes for patients with metastatic breast cancer treated with eribulin: a post hoc pooled analysis

Implications of Iron Deficiency in STEMI Patients and in a Murine Model of Myocardial Infarction

Improving access to oncology publications for advocates and people with cancer

Inactivation of EMILIN-1 by Proteolysis and Secretion in Small Extracellular Vesicles Favors Melanoma Progression and Metastasis

Incidence and characteristics of adverse drug reactions in a cohort of patients treated with PD-1/PD-L1 inhibitors in real-world practice

Inclusion of non-inferiority analysis in superiority-based clinical trials with single-arm, two-stage Simon's design

Incorporating Alternative Polygenic Risk Scores into the BOADICEA Breast Cancer Risk Prediction Model

Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia

INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors